CIS is Now Using New Treatment for Varicose Veins

HOUMA- Interventional cardiologist Dr. Pradeep Nair is the first at Cardiovascular Institute of the South to utilize the Varithena treatment for varicose veins.

Varithena, a polidocanol injectable foam, is a prescription medication used to treat varicose veins caused by problems with the great saphenous vein system in the leg.  Through the use of a catheter, the foam is injected into the malfunctioning vein.  The diseased vein collapses, and blood flow shifts to healthier veins nearby.

This minimally-invasive, non-surgical treatment doesn’t require incisions or the use of heat, a wire or glue.  The foam dissolves in the bloodstream after treatment, leaving no foreign bodies in the vein.


Back row: Kevin England, BTG Territory Manager; Matt Thornbrough, BTG Clinical Specialist; and Dr. Pradeep Nair, MD
Front row: Ashley Guidry, CMA; Mary-Beth Clement, LPN; and Angel Duplantis, RVS.

“CIS is proud to offer this new treatment option for our patients who suffer with varicose veins and associated symptoms such as leg discomfort, swelling, skin discoloration or ulcerations,” said Dr. Nair.  “One of the benefits of this treatment is that it is minimally-invasive and more comfortable for the patient without the need for multiple needle sticks. It is highly effective and successful in treating venous disease.” 

Symptoms of venous disease include the following:

  • Swelling or heaviness in legs
  • Leg pain or cramping
  • Visible varicose or spider veins
  • Discoloration of skin
  • Dry or weeping eczema
  • Leg ulcers
  • Restless legs

To learn more about the vein treatments available at CIS, call the clinic nearest you or visit


Latest News

CIS Staff

Written by CIS Staff